Goldman Sachs: 5 Stocks, Including Nvidia, Too Attractive to Ignore

• Goldman Sachs identifies five compelling stocks, including Nvidia, as highly attractive despite market volatility.
• Teva Pharmaceuticals is deemed a strong buy with a rapidly ascending earnings trajectory and robust pipeline; price target raised to $45.
• Philip Morris is transforming into a faster-growing, more profitable business with an attractive valuation and aggressive 2026 outlook.
• S&P Global shows strong AI positioning, conservative guidance, and durable long-term earnings power, despite recent pullback.
• Apollo Global is highlighted as an alternative asset manager with healthy upside potential, insulated from industry risks.